Abstract
Nephronophthisis (NPHP) is an autosomal recessive disease manifesting as tubulointerstitial nephritis uniformly progressing to ESRD in approximately 5–10% patients in childhood. Living donor transplantation is the most beneficial mean of renal replacement therapy compared to other methods. However, living kidney donation is contraindicated in potential donor with diseases of autosomal dominant mode of inheritance potentially leading to kidney failure in future. On the other hand, autosomal recessive genetic kidney diseases, such as NPHP, are not usually contraindication to living kidney donation. Herein, we are reporting related living kidney transplantation with a family history of NPHP form 46-year-old mother (heterozygote) to 17-year-old daughter with (autosomal recessive homozygote) with focus on donor follow-up after nephrectomy.
References
1.
Fanconi
G
, Hanhart
E
, von Albertini
A
, Uhlinger
E
, Dolivo
G
, Prader
A
. [Familial, juvenile nephronophthisis (idiopathic parenchymal contracted kidney)]
. Helv Paediatr Acta
. 1951
;6
(1
):1
–49
.2.
Wolf
MTF
, Hildebrandt
F
. Nephronophthisis
. Pediatr Nephrol
. 2011
;26
(2
):181
–94
. 3.
Braun
DA
, Hildebrandt
F
. Ciliopathies
. Cold Spring Harb Perspect Biol
. 2017
;9
(3
):a028191
.4.
Hildebrandt
F
, Zhou
W
. Nephronophthisis-associated ciliopathies
. J Am Soc Nephrol
. 2007
;18
(6
):1855
–71
. 5.
Bollée
G
, Fakhouri
F
, Karras
A
, Noël
LH
, Salomon
R
, Servais
A
, et al Nephronophthisis related to homozygous NPHP1 gene deletion as a cause of chronic renal failure in adults
. Nephrol Dial Transplant
. 2006
;21
(9
):2660
–3
. 6.
Salomon
R
, Saunier
S
, Niaudet
P
. Nephronophthisis
. Pediatr Nephrol
. 2009
;24
(12
):2333
–44
. 7.
Alhusaini
OA
, Wayyani
LA
, Dafterdar
HE
, Gamlo
MM
, Alkhayat
ZA
, Alghamdi
AS
, et al Comparison of quality of life in children undergoing peritoneal dialysis versus hemodialysis
. Saudi Med J
. 2019
;40
(8
):840
–3
. 8.
Weiz
J
, Koch
M
, Mehrabi
A
, Schemmer
P
, Zeier
M
, Beimler
J
, et al Living-donor kidney transplantation: risks of the donor: benefit of the recipient
. Clin Transplant
. 2006
;20
(17
):13
–6
.9.
Cecka
JM
. Kidney transplantation in United States
. Clin Transplant
. 2008
;22
:1
–18
.10.
Avci
B
, Kazanci
O
, Baskin
E
, Gulleroglu
K
, Akdur
A
, Ayvazoglu
S
, et al Our experience of patients with juvenile nephronopthisis after renal transplantation
. Transplantation
. 2018
;102
:S297
.11.
Lentine
KL
, Kasiske
BL
, Levey
AS
, Adams
PL
, Alberú
J
, Bakr
MA
, et al Summary of kidney disease: improving global outcomes (KDIGO) clinical practice guideline on the evaluation and care of living kidney donors
. Transplantation
. 2017
;101
(8
):1783
–92
. 12.
Momtaz
HE
, Tanasan
A
, Afkhami
M
. A case of non-compaction of left ventricle coexistent with juvenile nephronophthisis. Is this another presentation of ciliopathy?
J Ped Nephrol
. 2014
;2
(1
):46
–9
.13.
Garg
AX
, Prasad
GV
, Thiessen-Philbrook
HR
, Ping
L
, Melo
M
, Gibney
EM
, et al Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada
. Transplantation
. 2008
;86
(3
):399
–406
. 14.
Boudville
N
, Prasad
GV
, Knoll
G
, Muirhead
N
, Thiessen-Philbrook
H
, Yang
RC
, et al Meta-analysis: risk for hypertension in living kidney donors
. Ann Intern Med
. 2006
;145
(3
):185
–96
. 15.
Reese
PP
, Feldman
HI
, Asch
DA
, Thomasson
A
, Shults
J
, Bloom
RD
. Short-term outcomes for obese live kidney donors and their recipients
. Transplantation
. 2009
;88
(5
):662
–71
. © 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
